Setback for Lundbeck as EU court adviser backs EU antitrust fine

BRUSSELS (Reuters) - Danish drugmaker Lundbeck's fight against a 2013 EU antitrust fine imposed for deals with rivals to delay sales of generic copies of its anti-depressant citalopram hit a hurdle after a top court adviser said its appeal should be rejected.Drugmakers have fought a lengthy battle for "pay-for-delay" deals against antitrust regulators on both sides of the Atlantic who say such agreements hurt competition and hold back innovation.The European Commission had fined Lundbeck and..